Andrew Bohm

Title: The Innovations of Andrew Bohm

Introduction

Andrew Bohm is a notable inventor based in Armonk, NY (US). He has made significant contributions to the field of biochemistry, particularly in the area of macrophage colony-stimulating factor (M-CSF). With a total of 2 patents, his work has implications for both therapeutic and research applications.

Latest Patents

Bohm's latest patents include innovative methods for crystallizing macrophage colony-stimulating factor. The first patent focuses on the identification of M-CSF agonists and antagonists, detailing methods for designing and producing these compounds based on the crystallographic structure of M-CSF. Additionally, it outlines methods for screening M-CSF agonists and antagonists. The second patent involves the crystallization of M-CSF.alpha., which is crucial for understanding the receptor's functionality.

Career Highlights

Andrew Bohm is currently associated with Chiron Corporation, where he continues to advance his research in biochemistry. His work has been instrumental in developing new therapeutic strategies that leverage the properties of M-CSF.

Collaborations

Bohm has collaborated with notable colleagues such as Jayvardhan Pandit and Jarmila Jancarik, contributing to a rich environment of innovation and discovery.

Conclusion

Andrew Bohm's contributions to the field of biochemistry through his patents and collaborations highlight his role as a significant inventor. His work on M-CSF agonists and antagonists paves the way for future advancements in therapeutic applications.